Quick answer
A health insurance requirement that a prescriber obtain plan approval before a covered drug will be paid for. Prior authorization is nearly universal for GLP-1 RAs in 2026.
Full definition
Prior authorization (PA) is a utilization management process by which insurers require providers to obtain approval before dispensing covered medications. For GLP-1 RAs, PA typically requires documented diagnosis (T2D HbA1c, BMI plus comorbidity for obesity), prior trial of formulary alternatives (step therapy), labs, and ongoing demonstration of benefit (HbA1c reduction or 5%+ weight loss at re-authorization). PA denials can be appealed. Average GLP-1 PA approval rates vary by plan, indication, and documentation quality.
Deep dive
Prior Authorization (PA): complete reference
Prior authorization (PA) is an insurance requirement that a prescriber justify medical necessity для a specific medication before insurance will cover it. For GLP-1 medications, PA is typical для weight indications (sometimes для diabetes индicaations too). Documentation typically required: BMI ≥30 (or ≥27 с comorbidity), recent A1C if diabetic, 3-6 months of documented lifestyle intervention failure, failed prior weight-loss medications, contraindication screening (no MTC/MEN 2 history). Submission process: prescriber portal → 24-72 hour turnaround → approval, denial с rationale, or request for additional info. Denials are common первое раз; appeal protocol involves: written denial reason, formulary exception request с medical necessity letter citing FDA label + clinical guidelines + patient-specific factors, escalation to external review if denied again. Many initial denials reverse on appeal with proper documentation. PA expiration: typically 6-12 months; renewal required at expiration.
- In practice
- Your prescriber writes для Wegovy → pharmacy says "needs prior auth" → prescriber's office submits forms → 2-3 days later you get approval or denial. If denied, your prescriber can appeal with stronger documentation.
- Clinical context
- PA is standard для GLP-1 weight indications. Denials common первый pass; appeals frequently reverse them.
Medications
Prior Authorization (PA) is most directly relevant to the following GLP-1 medications:
Related terms
- Step Therapy — An insurance policy requiring patients to first try less expensive medications before approving a mo…
- Formulary — The list of drugs an insurance plan covers, organized into tiers with different copays. GLP-1 RAs ty…
Continue learning
GLP1Zoom glossary is educational reference. Definitions are summary interpretations of clinical sources and not a substitute for prescribing-information detail. Full disclaimer.
References
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms и Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity(2015)
STEP-1 trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding et al., NEJM)(2021)
SURMOUNT-1 trial: Tirzepatide Once Weekly для Treatment of Obesity (Jastreboff et al., NEJM)(2022)
SUSTAIN-6 trial: Semaglutide and Cardiovascular Outcomes (Marso et al., NEJM)(2016)
SURPASS-2 trial: Tirzepatide vs Semaglutide в Type 2 Diabetes (Frias et al., NEJM)(2021)
LEADER trial: Liraglutide and Cardiovascular Outcomes в T2D (Marso et al., NEJM)(2016)